Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Schmidt Rearrangement. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111574475B details a novel synthesis route for RSV drug intermediates, offering improved solubility and cost reduction in API manufacturing through optimized catalytic steps.
Patent CN112979665B details novel griseofulvin derivatives with potent antitumor activity via Schmidt rearrangement, offering cost-effective routes for API intermediates.